BiotechTube
Home/XENSE/Sean Lavine, MD
SL

Sean Lavine, MD

Head of Medical Affairs & Investor

XENSE

Therapeutic Areas

NeurologicalPsychiatric

XENSE Pipeline

DrugIndicationPhase
uTomo Platform DevelopmentNeurological and Psychiatric Conditions (Digital Biomarkers/Diagnostics)Pre-clinical

Leadership Team at XENSE

YZ
Ying Zhao
CEO, CTO and Founder
AK
Alexander Khal
Role not fully specified
View full XENSE profile